2004-004824-11: Role for pimecrolimus in restoring skin barrier function and normalizing epidermal lipid content and differentiation in atopic epidermis: a randomized, intra-patient, double-blind (right/left arm) study in adults with atopic dermatitis treated with 1% pimecrolimus cream and 0.1 % betamethasone cream as treatment control twice daily for 3 weeks |
|
|
| Completed | 4 | 15 | Europe | Elidel 1 % cream, Betnesol-V-cream 0.1 %, Elidel 1% Cream, Betnesol V-Creme 0.1 %, Elidel 1% Cream, Betnesol V-Creme 0.1 % | Universitätshautklinik Kiel | Atopic Dermatitis | | | | |
2018-004370-96: The effects of topical corticosteroid use on insulin sensitivity and bone turnover Effekten af binyrebarkhormon lokalbehandling på udvikling af diabetes og knogleskørhed |
|
|
| Not yet recruiting | 4 | 36 | Europe | Betnovate (Betamethasone) 0.1% ointment, Protopic (Tacrolimus) 0.1 % ointment | Jacob Pontoppidan Thyssen, LEO Pharma A/S, Innovation Fund Denmark, Aage Bang's Fund | Atopic dermatitis, Atopic eczema, Body processes [G] - Physiological processes [G07] | | | | |
